Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Peptide Fragments  [Clear All Filters]
Ebong IA, Wilson MD, Bertoni AG, et al. "High-sensitivity cardiac troponin T and the risk of heart failure in postmenopausal women of the ARIC Study." Menopause. 2021;28(3):284-291.
Ishigami J, Hoogeveen RC, Ballantyne CM, Folsom AR, Coresh JJ, Selvin E. "Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2019;188(12):2146-2155.
Liu S, Kim ED, Wu A, et al. "Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults." PLoS One. 2019;14(2):e0212892.
Pokharel Y, Mouhanna F, Schneider ALC, et al. "High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change." J Am Geriatr Soc. 2019;67(11):2353-2361.
Pandey A, Patel KV, Vongpatanasin W, et al. "Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis." Circulation. 2019;140(25):2076-2088.
Almuwaqqat Z, O'Neal WT, Norby FL, et al. "Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study." J Am Heart Assoc. 2019;8(19):e013294.
Whitman IR, Vittinghoff E, Defilippi CR, et al. "NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure." J Am Heart Assoc. 2019;8(7):e010868.
Mok Y, Sang Y, Ballew SH, et al. "Premorbid levels of high-sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction." Am Heart J. 2019;216:62-73.
Madan N, Lee AK, Matsushita K, Hoogeveen RC, Ballantyne CM, Selvin E. "Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study)." Am J Cardiol. 2019;124(2):245-252.
Juraschek SP, Daya N, Appel LJ, et al. "Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study." J Am Geriatr Soc. 2019;67(9):1795-1802.
C Quarta C, Buxbaum JN, Shah AM, et al. "The amyloidogenic V122I transthyretin variant in elderly black Americans." N Engl J Med. 2015;372(1):21-9.
Kim Y, Matsushita K, Sang Y, et al. "Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study." Am J Kidney Dis. 2015;65(4):550-8.
Lazo M, Rubin J, Clark JM, et al. "The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease." J Hepatol. 2015;62(4):841-7.
Folsom AR, Yao L, Alonso A, et al. "Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study." Circulation. 2015;132(7):578-85.
Bower JK, Lazo M, Matsushita K, Rubin J, Hoogeveen RC, Ballantyne CM. "N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study." Am J Hypertens. 2015;28(10):1262-6.
Gupta DK, Claggett B, Wells Q, et al. "Racial differences in circulating natriuretic peptide levels: the atherosclerosis risk in communities study." J Am Heart Assoc. 2015;4(5).
Roca GQuerejeta, Redline S, Claggett B, Bello N, Ballantyne CM, Solomon SD. "Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study." Circulation. 2015;132(14):1329-37.
Sinner MF, Stepas KA, Moser CB, et al. "B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies." Europace. 2014;16(10):1426-33.
Matsushita K, Sang Y, Ballew SH, et al. "Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study." Arterioscler Thromb Vasc Biol. 2014;34(8):1770-7.
Ndumele CE, Coresh JJ, Lazo M, et al. "Obesity, subclinical myocardial injury, and incident heart failure." JACC Heart Fail. 2014;2(6):600-7.
Folsom AR, Lutsey PL, Nambi V, Defilippi CR, Heckbert SR, Cushman M. "Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE)." Vasc Med. 2014;19(1):33-41.
Dadu RT, Fornage M, Virani SS, et al. "Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study." Stroke. 2013;44(7):1803-8.
Lazo M, Young HJ, Brancati FL, et al. "NH2-terminal pro-brain natriuretic peptide and risk of diabetes." Diabetes. 2013;62(9):3189-93.
Roca GQuerejeta, Redline S, Punjabi N, Claggett B, Ballantyne CM, Solomon SD. "Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study." Am J Respir Crit Care Med. 2013;188(12):1460-5.
Folsom AR, Nambi V, Bell EJ, et al. "Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study." Stroke. 2013;44(4):961-7.
Agarwal SK, Chambless LE, Ballantyne CM, et al. "Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study." Circ Heart Fail. 2012;5(4):422-9.
Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK. "Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb Vasc Biol. 2001;21(4):611-7.